Intervascular
Reporting payments is a legal requirement; large totals often reflect large product portfolios.
$10Kgeneral payments (2019-2025)
$0.00research payments (2019-2025)
14clinicians paid
General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.
General payments by year
General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.
Products most associated with its payments
Specialties it works with most
Clinicians with the largest reported totals
Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.
| Clinician | Location | Specialty | General payments (2019-2025) |
|---|---|---|---|
| Jeffrey Lawson | Durham, NC | Surgery | $1,430.00 |
| Jean Panneton | Virginia Beach, VA | Vascular Surgery | $715.00 |
| Daniel Clair | Nashville, TN | Vascular Surgery | $715.00 |
| Jake Scott | Stanford, CA | Infectious Disease | $715.00 |
| Sharif Ellozy | New York, NY | Vascular Surgery | $715.00 |
| Charles Ozaki | Boston, MA | Vascular Surgery | $715.00 |
| Samir Shah | Gainesville, FL | Vascular Surgery | $715.00 |
| Vance Fowler | Durham, NC | Infectious Disease | $715.00 |
| Edwin Gravereaux | Boston, MA | Vascular Surgery | $715.00 |
| Ann Woolley | Boston, MA | Infectious Disease | $655.00 |
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.